Ligand Pharmaceuticals LGND
NASDAQ LGND
$303.53 -4.29 (-1.39%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Ligand Pharmaceuticals (LGND) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Ligand Pharmaceuticals 6.05 Bn 2.51 Bn - 364.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 364.24 Mn
Mar 31, 2026 127.63 Mn
Dec 31, 2025 203.68 Mn
Sep 30, 2025 57.06 Mn
Jun 30, 2025 52.89 Mn
Mar 31, 2025 73.92 Mn
Dec 31, 2024 47.72 Mn
Sep 30, 2024 95.48 Mn
Jun 30, 2024 49.32 Mn
Mar 31, 2024 77.41 Mn
Dec 31, 2023 59.98 Mn
Sep 30, 2023 24.90 Mn
Jun 30, 2023 56.88 Mn
Mar 31, 2023 52.83 Mn
Dec 31, 2022 7.10 Mn
Sep 30, 2022 25.00 Mn
Jun 30, 2022 44.69 Mn
Mar 31, 2022 157.70 Mn
Dec 31, 2021 31.77 Mn
Sep 30, 2021 4.32 Mn
API Access

Ligand Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LGND&period=max&api_key=YOUR_API_KEY